Tag : clinical trials

Neurology

Blood Pressure Treatment Reduces Bleeding in ICH

Newsemia
Compared with standard treatment, intensive blood pressure lowering does not improve function but does appear to reduce hematoma growth, a new study suggests. Medscape Medical...
Neurology

Mind Menders: The Future of Psychedelic Therapy in the US

Newsemia
From LSD to psilocybin, psychedelics have the potential to revolutionize treatment of psychiatric disorders. Expert Roland R. Griffiths, PhD, discusses the status of psychedelic research...
Neurology

New 'Wake-up' Stroke Analysis Strengthens Case for Thrombolysis

Newsemia
Thrombolysis was associated with better functional outcomes for patients with ischemic stroke of unknown time of onset selected by advanced imaging techniques in a new...
Neurology

CBD Users May Test Positive for Marijuana on Urine Drug Screen

Newsemia
Tetrahydrocannabinol, the psychoactive ingredient in marijuana, was found in 50% of urine samples from individuals using cannabidiol oil (CBD). Medscape Medical News Source link...
Neurology

How Cannabis-Based Therapeutics Could Help Fight COVID Inflammation

Newsemia
Researchers specializing in cannabinoid therapeutics believe such therapies have a special role to play in treating COVID-19 and the cytokine storm. Medscape Medical News Source...
Neurology

End of the Road for High-Dose Biotin in MS?

Newsemia
High-dose biotin, a B vitamin used at lower doses as a food supplement, does not significantly improve disability or walking speed in patients with progressive...
Neurology

'Landmark' Study Pushed Detection of Covert Consciousness in TBI

Newsemia
Recent research has led to a "sea change" in guidelines and accelerated momentum in research to better detect signs of consciousness after traumatic brain injury...
Neurology

ODCI Gene Linked to New Neurodevelopmental Disorder

Newsemia
A mutation of the ODC1 gene has been implicated in a syndromic neurodevelopmental disorder first described in 2018 and linked to a number of dysmorphic...
Neurology

CDC Panel Takes on COVID Vaccine Rollout, Risks, and Side Effects

Newsemia
CDC’s vaccine advisers were briefed Friday on potential approaches for a COVID vaccine rollout and a method for tracking adverse events of these shots. Medscape...
Neurology

Positive Topline Results for New Cervical Dystonia Treatment

Newsemia
DaxibotulinumtoxinA for treatment of cervical dystonia met the primary and secondary endpoints in the ASPEN-1 phase 3 trial, Revance Therapeutics reports. Medscape Medical News Source...
Neurology

ECT for Bipolar Disorder: Across-the-Board Symptom Relief

Newsemia
Electroconvulsive therapy achieved response rates of more than 80% for all symptoms of bipolar disorder and remission rates of more than 60% for several features,...
Neurology

Safety Concern With Fingolimod to Ocrelizumab Switch in MS

Newsemia
A new study has suggested that some patients who make this switch may experience "double immunosuppression" – very low levels of both T and B...
Dermatology

Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting.

Newsemia
Related Articles Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting. Curr Opin Oncol. 2020 03;32(2):106-113 Authors: Herrscher H, Robert C Abstract...
Dermatology

Targeting BRAF and MEK inhibitors in melanoma in the metastatic, neoadjuvant and adjuvant setting.

Newsemia
Related Articles Targeting BRAF and MEK inhibitors in melanoma in the metastatic, neoadjuvant and adjuvant setting. Curr Opin Oncol. 2020 03;32(2):85-90 Authors: Tétu P, Baroudjian...
Neurology

Optimal Dose of Fingolimod for Multiple Sclerosis Confirmed

Newsemia
The 0.5-mg dose of fingolimod provides a greater reduction in annualized relapse rate vs both the 0.25-mg dose of fingolimod and the 20-mg dose of...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy